Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Partial response rate reported in Davant phase II trial for colorectal cancer

Oct. 16, 2007

CP-4126 well tolerated in solid tumor patients

Oct. 16, 2007

Enrollment completed in phase I trial of Lenocta

Oct. 15, 2007

Proteolix initiates carfilzomib study in relapsed solid tumors patients

Oct. 15, 2007

C-Path and Ventana collaborate on targeted therapy initiative with FDA and NCI

Oct. 15, 2007

Pharmion and MethylGene evaluate MGCD-0103 and Taxotere combination for solid tumors

Oct. 15, 2007

Polyunsaturated fatty acid erythrocyte content, biomarker of colorectal cancer risk

Oct. 15, 2007

National Cancer Institute awards SBIR contract to Rules-Based Medicine

Oct. 11, 2007

GlaxoSmithKline and Synta collaborate for STA-4783 in oncology

Oct. 11, 2007

OXI-4503 well tolerated in ongoing phase I study

Oct. 11, 2007

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...